We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock

Delisted

VINC was delisted on the 22nd of April, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
PM
1
Prosight Management
Texas
$2.02M +$3.12M +124,421 New
AC
2
Armistice Capital
New York
$1.61M +$2.49M +99,400 New
SRC
3
Sage Rhino Capital
California
$1.38M
RSCM
4
Rock Springs Capital Management
Maryland
$722K
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$546K -$352K -14,031 -29%
Goldman Sachs
6
Goldman Sachs
New York
$511K -$100 -4 -0%
Vanguard Group
7
Vanguard Group
Pennsylvania
$508K -$49.6K -1,978 -6%
ECM
8
ExodusPoint Capital Management
New York
$387K +$202K +8,066 +51%
Marshall Wace
9
Marshall Wace
United Kingdom
$266K +$322K +12,849 +359%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$187K +$60.6K +2,415 +26%
Citadel Advisors
11
Citadel Advisors
Florida
$144K
Renaissance Technologies
12
Renaissance Technologies
New York
$105K +$10.9K +436 +7%
RCMNY
13
Rubric Capital Management (New York)
New York
$94.7K
State Street
14
State Street
Massachusetts
$46.2K
BlackRock
15
BlackRock
New York
$38.1K
Northern Trust
16
Northern Trust
Illinois
$27.8K -$25 -1 -0.1%
XT
17
XTX Topco
Cayman Islands
$14.7K +$22.8K +909 New
Two Sigma Investments
18
Two Sigma Investments
New York
$13.8K +$21.4K +851 New
Millennium Management
19
Millennium Management
New York
$9.27K -$18.2K -725 -56%
LPL Financial
20
LPL Financial
California
$8.32K -$4.39K -175 -25%
HCM
21
Hollencrest Capital Management
California
$8.1K
LP
22
LMR Partners
United Kingdom
$8.1K
Focus Partners Wealth
23
Focus Partners Wealth
Massachusetts
$8K
TRCT
24
Tower Research Capital (TRC)
New York
$6.4K +$4.22K +168 +74%
Morgan Stanley
25
Morgan Stanley
New York
$1.42K -$22.4K -893 -91%